-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Richard C Godby, MD1, Myra Wick, MD, PhD1*, Mingchun Liu, MD1*, Rachael F. Grace, MD, MMSc2, Ronald S Go, M.D.3, Meera Sridharan, MD PhD1, Sara Gasner, RN1*, Vanessa Torbenson, MD1*, Katherine Talbott, MD1*, Danette Bruns1*, Jen Burt1*, Jessica Gonzalez1*, Jamie Petsch1* and Matthew Warner, MD1*

1Mayo Clinic, Rochester, MN
2Boston Children's Hospital, Boston, MA
3Division of Hematology, Mayo Clinic, Rochester, MN

Shreyans Gandhi, MD, MBBS, DNB, FRCPath, MPhil, MRCP1*, Regis Peffault De Latour2,3,4*, Katharina Pannagl5*, Maria-Magdalena Balp6*, Anggie Wiyani5*, Cheryl Druchok7*, Paul Lebeau7* and Richard J. Kelly, MBChB, PhD8*

1Kings College Hospital, NHS Foundation Trust, London, United Kingdom
2French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
3The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation, Barcelona, Spain
4Université Paris Cité, Paris, France
5Novartis Pharmaceuticals UK Ltd, London, United Kingdom
6Novartis Pharma AG, Basel, Switzerland
7EVERSANA, Burlington, ON, Canada
8Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Alice Kuaban, MS1*, Alysha Croker, PhD2*, Jeffrey Keefer, MD, PhD3*, Leonard A. Valentino, MD4, Alan E. Mast, MD, PhD5 and Stephanie Valerie Seremetis, MD6

1American Society of Hematology, Washington DC
2Health Canada, Ottowa, ON, Canada
3IQVIA, Baltimore, MD
4Pathway to Cures, National Bleeding Disorders Foundation, New York, NY
5Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, WI
6Novo Nordisk, Plainsboro, NC

Rishabh Singh, MD1, Jacob Cogan, MD2, Caroline Cromwell, MD3, Manila Gaddh, MD4, Radhika Gangaraju, MD5, Ming Y Lim, MBBChir6, Colleen T. Morton, MD7, Andrew M. Peseski, DO8, Rachel P. Rosovsky, MD9, Ishan J Tatake, MD10, Kimberley Youkhana, MD, MSCR11 and Lisa Baumann Kreuziger, MD, MS12,13

1Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL
2Classical Hematology, University of Minnesota, Minneapolis, MN
3Icahn School of Medicine, Hematology and Medical Oncology, Mount Sinai, New York, NY
4Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
5Division of Hematology and Oncology, Department of Medicine, University Of Alabama at Birmingham, Birmingham, AL
6Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah Health, Salt Lake Cty, UT
7Vanderbilt, Nashville, TN
8Division of Hematology, Duke University Medical Center, Durham, NC
9Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
10Department of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Brookline, MA
11Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC
12Versiti, Milwaukee, WI
13Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee

Lucy C Fox, BSc, FRACP, FRCPA, MBBS1,2,3, Nicole Den Elzen4*, Erin Goode4*, Kelsey Man4*, Lin Cheng5*, Stephanie Best5*, Jillian Francis5*, Laura Barth6*, Paul James4*, Karin A Thursky, MBBS, FRACP, PhD2,7*, Ashish Bajel, MBBS, FRACP, FRCPA1,8, David S. Ritchie, MBChB PhD9,10 and Piers Blombery, MBBS2,11

1Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
3Transfusion Research Unit, Monash University, Melbourne, Australia
4Peter MacCallum Cancer Centre, Melbourne, Australia
5School of Health Sciences, University of Melbourne, Melbourne, Australia
6Genetics Department, Monash Health, Melbourne, Australia
7Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
8Department of Medicine, University of Melbourne, Melbourne, Australia
9Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
10Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
11Molecular Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia

Armaan Dhaliwal, MBBS1, Chun Siu, DO1*, Derek Lillestolen, DO2*, Kathryn Zaffiri, MPH2* and Bradley W. Lash, MD1

1John & Dorothy Morgan Cancer Center, Lehigh Valley Health Network, Allentown, PA
2Lehigh Valley Health Network, Allentown, PA

Justin Senecal, MD, BSc1*, Yasmine Madan2*, Sabina Rajkumar3*, Rabia Tahir2*, Mark A. Crowther, MD, MSc, FRSC, FRCPC, LLM1,4 and Siraj Mithoowani, MD FRCPC5

1Department of Medicine, McMaster University, Hamilton, ON, Canada
2McMaster University, Hamilton, ON, Canada
3McMaster University, Hamilton, Canada
4Department of Medicine, McMaster University, Hamilton, Canada
5McMaster University, Hamilton, ON, CAN

Lisa Dorn, MD, PhD*, Elissa Engel, MD, Tanya Perry, DO* and Lori Luchtman-Jones, MD

Cincinnati Children's Hospital, Cincinnati, OH

Tung Wynn, MD1, Christopher Walsh, MD, PhD2, Jeanette Cesta3*, Robert F Sidonio Jr., MD4*, Stefanie Dugan, MS5* and Mona Sayedul Huq, PhD1*

1University of Florida, Gainesville, FL
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3VWD Connect Foundation, West Palm Beach, FL
4Emory University School of Medicine, Atlanta, GA
5Versiti’s Comprehensive Center for Bleeding Disorders, Milwaukee, WI

Archana Ramgopal, DO1, Breana Goscicki, PharmD2*, Shiva Sridar3*, Li Wang4*, Daniel Klein5*, Ram Kalpatthi, MD6* and Jignesh Dalal, MD7*

1Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
2Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
3Tufts University School of Medicine, Boston, MA
4University of Pittsburgh, Pittsburgh, PA
5UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
6Department of Pediatrics, Division of Pediatric Hematology Oncology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
7Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH

Asavari Rajpurkar, MD1* and Angela C Weyand, MD2

1University of Michigan Department of General Surgery, Ann Arbor, MI
2Division of Hematology/Oncology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI

Shelley V Crary, MD1*, Lilianne B McKissack2*, Joana M Mack, MD1*, Saritha Ranabothu, MD3*, Megan E Rogers2* and Shelley E Crary, MD, MS1

1Pediatric Hematology/Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
2College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
3Pediatric Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR

Kalaivani Babu, MBBS1, Srinishant Rajarajan, MBBS1, Arya Mariam Roy, MD2, Amit Correa, MD3*, Nithya Ramesh, MD4, Sruthi P Ramanan, MBBS5, Asmi Chattaraj4, Kriti Dhamija4*, Eiraj Khan6* and Adanma Anji Ayanambakkam Attanathi, MD7*

1Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
2Rosewell Park Cancer Center, Buffalo, NY
3Memorial Hermann, McGovern Medical School, Houston
4Allegheny General Hospital, Pittsburgh, PA
5Allegheny General hospital, Pittsburgh, PA
6Allegheny General Hospital, pittsburgh
7Oklahoma University Health Sciences, Oklahoma City, OK

Reema Miria Abraham, MD, MBBS, DM, DNB1*, Bitty Kurian, MSc2*, Nivedita Suresh, MD, MBBS1*, Seethalmol CB, BSC3*, Asha MK, DMLT4*, Meera M, MBBS, MD, PDF4*, Georg Gutjahr4*, Anandkrishnan N5*, Neeraj Sidharthan, MD, MBBS, DM, DNB6 and Jecko Thachil7*

1Department of Pathology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetam, Kochi, Kerala, India
2Department of Pathology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetam, Kochi, India
3Amrita institute of Medical sciences and research centre, Kochi, ERNAKULAM, India
4Amrita institute of Medical sciences and research centre, Kochi, Ernakulam, India
5Amrita school of physical sciences, Kochi, Ernakulam, India
6Department of Clinical Haematology, Transplant and Cellular Therapy , Amrita Institute of Medical Sciences and Research Centre, Co-Director Amrita Amyloid Center, Amrita Vishwa Vidyapeetham, Kochi, India
7Manchester Royal Infirmary, Manchester, ENG, United Kingdom

*signifies non-member of ASH